Latest News

Drug shows potential to delay onset or progression of Alzheimer's disease

An anti-atherosclerosis drug greatly reduced blood-brain barrier (BBB) leaks in animal models with diabetes and hypercholesterolemia and linked BBB permeability with amyloid peptide deposits at the site of early Alzheimer's pathology.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • A bad buzz: Men with HIV need fewer drinks to feel effects

  • Listen to your heart: Why your brain may give away how well you know yourself

  • Mindfulness-based therapy could offer an alternative to antidepressants for preventing depression relapse

  • New guideline advises when to treat a first seizure

  • Extending natalizumab up to 8 weeks shown safe and effective in patients with multiple sclerosis, report says

  • PTSD common in ICU Survivors

  • Frequent indoor tanning among teens shows correlation with smoking, social media use

  • Autism-epilepsy connection explored in four studies

  • Video games in care homes: connecting older adults, or exposing age-related vulnerability?

  • Reducing global tobacco use

  •